您的位置: 首页 > 农业专利 > 详情页

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
专利权人:
Idera Pharmaceuticals; Inc.
发明人:
Ekambar R. Kandimalla,Daqing Wang,Dong Yu,Ireneusz Nowak,Sudhir Agrawal
申请号:
US14149899
公开号:
US09260719B2
申请日:
2014.01.08
申请国别(地区):
US
年份:
2016
代理人:
摘要:
The invention provides immune regulatory oligonucleotides (IRO) as antagonist of TLRs and methods of use thereof. These IROs have unique sequences that inhibit TLR-mediated signaling in response to a TLR ligand or TLR agonist. The methods may have use in the prevention and treatment of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin disorders, allergy, asthma or a disease caused by a pathogen.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充